Cancer Therapy
Researchers from Spanish National Cancer Center discuss findings in cancer therapy
Published in Cancer Weekly, May 15th, 2007
Current study results from the report, "Molecular alterations associated with bladder cancer progression," have been published. "Clinically, superficial tumors (stages Ta, Tis, and T1) account for 75% to 85% of bladder neoplasms, while the remaining 15% to 25% are invasive (T2, T3, T4) or metastatic lesions at the time of initial presentation. More than 70% of patients with superficial tumors will have one or more recurrences after initial treatment, and about one third of those patients will progress and eventually die of the disease," scientists writing in the journal Seminars In Oncology report.
"New methods are needed to identify and monitor patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-05-15)
More Articles from Cancer Weekly
- Monoclonal Antibodies
Magnesium loss in patients given monoclonal antibodies - Actavis
Sindan to rebrand as Actavis - Anemia
Researchers Urge Caution in Using ESAs for Cancer-Related Anemia - Angiogenesis
AngioGenex/BioCheck Collaboration Produces Novel Antibodies, Revenue and Progress toward a Cancer Diagnostic - Bird Flu
CEL-SCI's Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals - Bladder Cancer
Spectrum Pharmaceuticals Initiates Phase 3, Registrational Trials With EOquin in Non-Invasive Bladder Cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
